| Literature DB >> 21512524 |
I Hyun1.
Abstract
The ability to generate human induced pluripotent stem (iPS) cells presents exciting prospects for drug discovery and the development of safer, more effective drugs. Given the enormous potential for iPS cell-based drug development, what ethical issues could possibly cloud this new biomedical horizon?Entities:
Mesh：
Year: 2011 PMID： 21512524 DOI： 10.1038/clpt.2010.308
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN： 0009-9236 Impact factor: 6.875